helicobacter pylori kx2 npgec | burkholderia pseudomallei | lactobacillus acidophilus | helicobacter pylori kx2 mgep | helicobacter pylori kx1 npgec | GeneSet Name |
-0.00740 | -0.00050 | -0.00055 | -0.01305 | -0.00205 | SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP |
-0.00217 | -0.00001 | -0.00010 | -0.02663 | -0.00036 | MOOTHA_VOXPHOS |
-0.00489 | -0.00532 | -0.00129 | -0.06916 | -0.00733 | ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_UP |
-0.00691 | -0.00033 | -0.00004 | -0.06632 | -0.00042 | CORUM_RESPIRATORY_CHAIN_COMPLEX_I_HOLOENZYME_MITOCHONDRIAL |
-0.02710 | -0.04587 | -0.00399 | -0.03218 | -0.10536 | LOPEZ_MESOTELIOMA_SURVIVAL_TIME_UP |
-0.07181 | -0.02750 | -0.01815 | -0.05284 | -0.02611 | WILCOX_PRESPONSE_TO_ROGESTERONE_UP |
-0.00200 | -0.00078 | -0.00041 | -0.10206 | -0.00044 | KEGG_CITRATE_CYCLE_TCA_CYCLE |
-0.01845 | -0.00013 | -0.00004 | -0.09230 | -0.02188 | NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP |
-0.01338 | -0.10712 | -0.17298 | -0.08425 | -0.01278 | SCHLOSSER_SERUM_RESPONSE_AUGMENTED_BY_MYC |
-0.02622 | -0.00534 | -0.00308 | -0.12859 | -0.01467 | GRADE_COLON_CANCER_UP |
-0.02742 | -0.12467 | -0.00511 | -0.00144 | -0.00577 | DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN |
-0.03241 | -0.16861 | -0.17650 | -0.13670 | -0.02084 | HASLINGER_B_CLL_WITH_17P13_DELETION |
-0.00017 | -0.00016 | -0.00187 | -0.04124 | -0.00038 | BORCZUK_MALIGNANT_MESOTHELIOMA_UP |
-0.00121 | -0.00042 | -0.00006 | -0.07595 | -0.00349 | MONTERO_THYROID_CANCER_POOR_SURVIVAL_UP |
-0.01840 | -0.00068 | -0.04152 | -0.12498 | -0.02516 | BHATTACHARYA_EMBRYONIC_STEM_CELL |
-0.01661 | -0.01842 | -0.09912 | -0.19829 | -0.00963 | ALONSO_METASTASIS_UP |
-0.04464 | -0.00073 | -0.00892 | -0.08113 | -0.08108 | KUMAMOTO_RESPONSE_TO_NUTLIN_3A_DN |
-0.14677 | -0.06173 | -0.05067 | -0.16617 | -0.10592 | NCI_MITOTIC_TELOPHASE__CYTOKINESIS |
-0.09506 | -0.00149 | -0.00703 | -0.00161 | -0.19787 | SHEPARD_BMYB_TARGETS |
-0.00119 | -0.01882 | -0.15065 | -0.06727 | -0.00888 | NCI_PHOSPHORYLATION_OF_THE_APC_C |
-0.00737 | -0.12577 | -0.00110 | -0.01868 | -0.00531 | STEIN_ESRRA_TARGETS |
-0.03797 | -0.00036 | -0.12158 | -0.02112 | -0.02184 | THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN |
-0.00213 | -0.00005 | -0.00001 | -0.10251 | -0.01899 | NCI_PLK1_PATHWAY |
-0.00463 | -0.00001 | -0.00436 | -0.14035 | -0.05506 | IVANOVA_HEMATOPOIESIS_INTERMEDIATE_PROGENITOR |
-0.09283 | -0.00582 | -0.00856 | -0.06736 | -0.01075 | MARKEY_RB1_CHRONIC_LOF_UP |
-0.00979 | -0.02533 | -0.00201 | -0.15550 | -0.00182 | SANA_RESPONSE_TO_IFNG_DN |
-0.00260 | -0.00117 | -0.01395 | -0.06081 | -0.00243 | CAFFAREL_RESPONSE_TO_THC_DN |
-0.01435 | -0.03691 | -0.09600 | -0.04721 | -0.00297 | REACTOME_CENTROSOME_MATURATION |
-0.00786 | -0.03491 | -0.07899 | -0.01359 | -0.00206 | CORUM_F1F0-ATP_SYNTHASE_EC_3.6.3.14_MITOCHONDRIAL |
-0.00546 | -0.00001 | -0.00008 | -0.07568 | -0.00339 | BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN |
-0.02818 | -0.00177 | -0.05131 | -0.12405 | -0.00897 | LOPEZ_MBD_TARGETS |
-0.00684 | -0.00947 | -0.11114 | -0.07750 | -0.02086 | NCI_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS |
-0.00182 | -0.00046 | -0.00183 | -0.10879 | -0.00100 | WONG_MITOCHONDRIA_GENE_MODULE |
-0.00370 | -0.02454 | -0.02572 | -0.17913 | -0.01341 | NCI_AURORA_A_PATHWAY |
-0.00735 | -0.03193 | -0.00886 | -0.04505 | -0.00240 | REACTOME_G2_M_TRANSITION |
-0.02041 | -0.00096 | -0.00063 | -0.10197 | -0.00233 | REACTOME_GLUCOSE_REGULATION_OF_INSULIN_SECRETION |
-0.10049 | -0.16675 | -0.17867 | -0.00285 | -0.09674 | REACTOME_METABOLISM_OF_PROTEINS |
-0.00079 | -0.00006 | -0.12943 | -0.04079 | -0.00349 | SASAKI_ADULT_T_CELL_LEUKEMIA |
-0.00513 | -0.04259 | -0.03917 | -0.03476 | -0.00223 | KEGG_GLUTATHIONE_METABOLISM |
-0.02041 | -0.16673 | -0.19993 | -0.02284 | -0.00494 | KEGG_TERPENOID_BACKBONE_BIOSYNTHESIS |
-0.06442 | -0.00426 | -0.03586 | -0.10610 | -0.05999 | HONRADO_BREAST_CANCER_BRCA1_VS_BRCA2 |
-0.06791 | -0.04731 | -0.18289 | -0.06310 | -0.02545 | CORUM_CTCF-NUCLEOPHOSMIN-PARP-HIS-KPNA-LMNA-TOP_COMPLEX |
-0.10714 | -0.00334 | -0.15621 | -0.04512 | -0.07162 | PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_DN |
-0.01585 | -0.12827 | -0.00604 | -0.00656 | -0.00080 | REACTOME_CHOLESTEROL_BIOSYNTHESIS |
-0.01571 | -0.05144 | -0.08618 | -0.00605 | -0.00297 | REACTOME_FORMATION_OF_ATP_BY_CHEMIOSMOTIC_COUPLING |
-0.01875 | -0.15599 | -0.16729 | -0.11312 | -0.01078 | KEGG_BUTANOATE_METABOLISM |
-0.00061 | -0.09646 | -0.12283 | -0.00166 | -0.00292 | BIOCARTA_MPR_PATHWAY |
-0.00430 | -0.00725 | -0.00020 | -0.05369 | -0.00086 | STARK_PREFRONTAL_CORTEX_22Q11_DELETION_DN |
-0.00901 | -0.03319 | -0.00030 | -0.03129 | -0.02746 | PENG_LEUCINE_DEPRIVATION_DN |
-0.02703 | -0.00040 | -0.00066 | -0.08936 | -0.01394 | UDAYAKUMAR_MED1_TARGETS_UP |
-0.03117 | -0.00558 | -0.15776 | -0.17608 | -0.04662 | PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP |
-0.00281 | -0.01448 | -0.04943 | -0.09045 | -0.00671 | REACTOME_INACTIVATION_OF_APC_VIA_DIRECT_INHIBITION_OF_THE_APCOMPLEX |
-0.07577 | -0.02242 | -0.00916 | -0.18475 | -0.12253 | SHEPARD_CRUSH_AND_BURN_MUTANT_DN |
-0.02144 | -0.00299 | -0.00080 | -0.07933 | -0.01028 | XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_DN |
-0.00079 | -0.12647 | -0.00666 | -0.00209 | -0.00054 | KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_DEGRADATION |
-0.00203 | -0.02193 | -0.14447 | -0.06321 | -0.00873 | REACTOME_APCDC20_MEDIATED_DEGRADATION_OF_CYCLIN_B |
-0.00058 | -0.04011 | -0.01350 | -0.11512 | -0.00278 | SESTO_RESPONSE_TO_UV_C6 |
-0.01416 | -0.00127 | -0.00887 | -0.04893 | -0.02427 | TANG_SENESCENCE_TP53_TARGETS_DN |
-0.01410 | -0.00050 | -0.00029 | -0.16100 | -0.02533 | PENG_GLUTAMINE_DEPRIVATION_DN |
-0.00014 | -0.01297 | -0.02258 | -0.06693 | -0.00012 | NCI_REGULATION_OF_APC_C_ACTIVATORS_BETWEEN_G1_S_AND_EARLY_ANAPHASE |
-0.05807 | -0.13439 | -0.00068 | -0.08274 | -0.01616 | REACTOME_TRANSFORMATION_OF_LANOSTEROL_TO_CHOLESTEROL |
-0.03829 | -0.18074 | -0.14415 | -0.05512 | -0.01962 | FARMER_BREAST_CANCER_APOCRINE_VS_BASAL |
-0.08596 | -0.12341 | -0.15195 | -0.13997 | -0.09014 | NCI_BETA_OXIDATION_OF_DECANOYL_COA_TO_OCTANOYL_COA_COA |
-0.02222 | -0.00002 | -0.00286 | -0.08413 | -0.00903 | GOLDRATH_ANTIGEN_RESPONSE |
-0.00508 | -0.05827 | -0.00602 | -0.03996 | -0.00183 | NCI_FOXM1PATHWAY |
-0.00718 | -0.11862 | -0.00124 | -0.08620 | -0.00148 | NCI_TRANSFORMATION_OF_LANOSTEROL_TO_CHOLESTEROL |
-0.02705 | -0.00026 | -0.00012 | -0.16095 | -0.01003 | BENPORATH_CYCLING_GENES |
-0.00115 | -0.00001 | -0.00013 | -0.02468 | -0.00039 | REACTOME_ELECTRON_TRANSPORT_CHAIN |
-0.00372 | -0.00078 | -0.12135 | -0.00021 | -0.00233 | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_12 |
-0.05578 | -0.06084 | -0.01579 | -0.07556 | -0.09387 | OHASHI_AURKB_TARGETS |
-0.06224 | -0.00378 | -0.00069 | -0.05125 | -0.04330 | CORUM_RC_COMPLEX_DURING_G2/M-PHASE_OF_CELL_CYCLE |
-0.00018 | -0.00001 | -0.00617 | -0.00628 | -0.00033 | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_13 |
-0.00236 | -0.00001 | -0.06903 | -0.01552 | -0.00043 | KEGG_PARKINSONS_DISEASE |
-0.02012 | -0.00016 | -0.01315 | -0.00274 | -0.02101 | PRAMOONJAGO_SOX4_TARGETS_DN |
-0.00684 | -0.00796 | -0.03486 | -0.08702 | -0.00043 | KEGG_HUNTINGTONS_DISEASE |
-0.03792 | -0.00518 | -0.03769 | -0.05383 | -0.00853 | REACTOME_INTEGRATION_OF_ENERGY_METABOLISM |
-0.00657 | -0.00069 | -0.00627 | -0.06341 | -0.00959 | LEE_LIVER_CANCER_SURVIVAL_DN |
-0.00681 | -0.04056 | -0.05740 | -0.01189 | -0.01163 | KEGG_OOCYTE_MEIOSIS |
-0.08934 | -0.13468 | -0.15609 | -0.13483 | -0.08527 | NCI_BETA_OXIDATION_OF_OCTANOYL_COA_TO_HEXANOYL_COA |
-0.01433 | -0.01053 | -0.05067 | -0.05605 | -0.01507 | NCI_APC_CDC20_MEDIATED_DEGRADATION_OF_NEK2A |
-0.01525 | -0.12766 | -0.02277 | -0.07154 | -0.00444 | KEGG_PROPANOATE_METABOLISM |
-0.04914 | -0.04260 | -0.04967 | -0.00913 | -0.02860 | REACTOME_DIABETES_PATHWAYS |
-0.00530 | -0.00178 | -0.00039 | -0.05512 | -0.00294 | MOOTHA_MITOCHONDRIA |
-0.01593 | -0.02945 | -0.02032 | -0.08492 | -0.01232 | DAIRKEE_TERT_TARGETS_UP |
-0.00608 | -0.00046 | -0.09173 | -0.18262 | -0.00116 | TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_UP |
-0.00631 | -0.03686 | -0.00073 | -0.02890 | -0.00298 | STEIN_ESRRA_TARGETS_UP |
-0.04603 | -0.01642 | -0.06171 | -0.08659 | -0.03512 | RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_UP |
-0.00831 | -0.00246 | -0.03992 | -0.00090 | -0.00059 | CHEN_HOXA5_TARGETS_9HR_DN |
-0.04108 | -0.00119 | -0.00167 | -0.07322 | -0.02279 | POMEROY_MEDULLOBLASTOMA_PROGNOSIS_DN |
-0.03351 | -0.00016 | -0.00058 | -0.08225 | -0.07930 | FINETTI_BREAST_CANCER_BASAL_VS_LUMINAL |
-0.01430 | -0.02146 | -0.09461 | -0.07869 | -0.01300 | RAMASWAMY_METASTASIS_UP |
-0.01267 | -0.10845 | -0.12679 | -0.13285 | -0.00296 | NCI_RECRUITMENT_OF_MITOTIC_CENTROSOME_PROTEINS_AND_COMPLEXES |
-0.02830 | -0.00728 | -0.01819 | -0.03508 | -0.00940 | REACTOME_REGULATION_OF_INSULIN_SECRETION |
-0.01848 | -0.00004 | -0.00242 | -0.03223 | -0.01642 | LY_AGING_MIDDLE_DN |
-0.04457 | -0.10305 | -0.06189 | -0.08393 | -0.01327 | ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN |
-0.02908 | -0.00049 | -0.00052 | -0.08048 | -0.07132 | FINETTI_BREAST_CANCER_KINOME_RED |
-0.00238 | -0.01195 | -0.04969 | -0.10034 | -0.00776 | NCI_INACTIVATION_OF_APC_C_VIA_DIRECT_INHIBITION_OF_THE_APC_C_COMPLEX |
-0.18530 | -0.02186 | -0.12246 | -0.08874 | -0.05628 | BIOCARTA_AKAP95_PATHWAY |
-0.00740 | -0.13553 | -0.04825 | -0.02846 | -0.00278 | NUYTTEN_NIPP1_TARGETS_DN |
-0.00920 | -0.03184 | -0.05717 | -0.09820 | -0.01296 | OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_UP |
-0.00171 | -0.05126 | -0.08124 | -0.00769 | -0.00007 | NCI_FORMATION_OF_ATP_BY_CHEMIOSMOTIC_COUPLING |
-0.11744 | -0.00845 | -0.06708 | -0.18518 | -0.12270 | KEGG_PYRUVATE_METABOLISM |
-0.11704 | -0.12333 | -0.08770 | -0.15875 | -0.06947 | CORUM_OLIGOSACCHARYLTRANSFERASE_COMPLEX_STT3B_VARIANT |
-0.08118 | -0.03038 | -0.00101 | -0.17471 | -0.03156 | CORUM_RC_COMPLEX_DURING_S-PHASE_OF_CELL_CYCLE |
-0.00788 | -0.08891 | -0.00997 | -0.01330 | -0.00296 | CAIRO_HEPATOBLASTOMA_UP |
-0.00440 | -0.09261 | -0.13731 | -0.14118 | -0.00302 | KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION |
-0.00137 | -0.03217 | -0.16735 | -0.06448 | -0.01002 | REACTOME_PHOSPHORYLATION_OF_THE_APC |
-0.03135 | -0.00146 | -0.02111 | -0.13629 | -0.01175 | LINDGREN_BLADDER_CANCER_CLUSTER_1_DN |